FDA says more data needed to approve dry eye drug Aldeyra (NASDAQ:ALDX)
Iryna Drozd The FDA has refused to approve Aldeyra Therapeutics (NASDAQ:ALDX) drug reproxalap, citing insufficient evidence that the drug was ...
Tag: Drug
Lexaria Stock Jumps 20% on Positive GLP-1 Drug Delivery Study (NASDAQ:LEXX)
Rawpixel/iStock via Getty Images Lexaria Stock (NASDAQ:LEXX) rose 20% in morning trading Monday after the drug delivery company announced positive ...
MorphoSys Reports Positive Phase 3 Results for Myelofibrosis Drug Candidate (NASDAQ:MOR)
Bet_Noire/iStock via Getty Images MorphoSys(NASDAQ:MOR) said a Phase 3 study for its drug pelabresib met its primary endpoint in treating ...
Eli Lilly to add $4.1 billion in sales thanks to anti-obesity drug Zepbound
hapabapa/iStock Editorial via Getty Images Eli Lilly's Sales (New York Stock Exchange:LLY) recently approved weight-loss drug Zepbound could reach $4.1 ...
Novo Nordisk details cardiac benefits of weight-loss drug
hapabapa/iStock Editorial via Getty Images Novo Nordisk (NVO) announced Saturday that its FDA-approved weight loss therapy Wegovy, also known as ...
Jefferies Begins Purchase of Ironwood, Cites Potential for Drug Apraglutide (IRWD)
free of law Jefferies initiated coverage of Ironwood Pharmaceuticals (NASDAQ:IRWD) with a Buy rating, saying it believes the Street is ...
US FDA approves Lilly weight loss drug and will compete with Wegovy de Novo By Reuters
© Reuters. FILE PHOTO: An Eli Lilly and Company pharmaceutical manufacturing facility at 50 ImClone Drive in Branchburg, New Jersey, ...
US Authorities Seize $54 Million in Ethereum from Convicted Drug Trafficker
In recent developments, US authorities led by US Attorney Philip R. Sellinger successfully seized $54 million worth of ethereum (eth) ...
Eli Lilly slumps after cutting profit outlook despite rising weight-loss drug profits
Eli LillyLYLYIt posted better-than-expected third-quarter earnings on Thursday thanks to continued growth in sales of its anti-obesity drug Mounjaro, which ...
Pharma and PBM argue over rising drug costs amid public scrutiny
Nadzeya Haroshka Leading pharmaceutical lobbying group PhRMA and drug brokers known as pharmacy benefit managers (PBMs) have resumed their long-running ...
Recommended.
